We are pleased to inform the UP Diliman community that the Philippine Health Research Ethics Board (PHREB) has granted the UP Diliman Research Ethics Board (UPD REB) a Level 1 Accreditation for a period of one year, effective 03 October 2025 until 02 October 2026.

With this accreditation, the UPD REB is now operational and open to receiving applications for ethics review from UP Diliman. 

𝐹𝑜𝑟 𝑛𝑜𝑤, 𝑒𝑥𝑡𝑒𝑟𝑛𝑎𝑙 𝑎𝑝𝑝𝑙𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝑠 𝑤𝑖𝑙𝑙 𝑛𝑜𝑡 𝑏𝑒 𝑎𝑐𝑐𝑜𝑚𝑚𝑜𝑑𝑎𝑡𝑒𝑑.

PHREB List of accredited REBs/RECs

𝑾𝒉𝒂𝒕 𝑳𝒆𝒗𝒆𝒍 1 𝑨𝒄𝒄𝒓𝒆𝒅𝒊𝒕𝒂𝒕𝒊𝒐𝒏 𝑴𝒆𝒂𝒏𝒔

Level 1 accreditation is a probationary status given to new Research Ethics Boards to acquire experience in the review of research protocols. This level allows UPD REB to review research except clinical trials required for FDA registration of new drugs.

Research involving Indigenous Cultural Communities (ICCs) and Indigenous Peoples (IPs) must secure clearance from a PHREB Level 2 Accredited REC and coordination with approval from the National Commission on Indigenous Peoples (NCIP).

The UPD REB is working towards expanding its capacity to eventually accommodate proposals and protocols involving ICCs and IPs, in recognition of the significant research interest in this area.

PHREB Accreditation Policies and Requirements

𝑹𝒆𝒗𝒊𝒆𝒘 𝑪𝒐𝒔𝒕𝒔

For 2025, ethics review services will be free of charge for all UP Diliman Principal Investigators (PIs), with the generous support of the Office of the Chancellor. Students are exempt from fees. Any changes or prospective review fees for 2026 will be announced early next year.

𝑮𝒖𝒊𝒅𝒂𝒏𝒄𝒆 𝒂𝒏𝒅 𝑺𝒖𝒑𝒑𝒐𝒓𝒕

For more information, please check the following pages:

Submission

Review

FAQs

Resources

The UPD REB

For general inquiries and/or complaints not related to a specific study protocol submission, please use the 

UPD REB Non-Study Protocol-Related Communications Form.